Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1B |
| 2 |
Tesla
TSLA
|
+$697M |
| 3 |
Microsoft
MSFT
|
+$447M |
| 4 |
Accenture
ACN
|
+$439M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$421M |
Top Sells
| 1 |
CRH
CRH
|
+$2.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.01B |
| 3 |
Texas Instruments
TXN
|
+$1.97B |
| 4 |
Starbucks
SBUX
|
+$1.61B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$1.07B |
Sector Composition
| 1 | Technology | 32.41% |
| 2 | Financials | 11.84% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Healthcare | 9.02% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Ashland
ASH
$2.41B
| $6.24M | ﹤0.01% |
71,689
+54,745
| +323% | +$4.76M |
|
1352
Standard BioTools
LAB
$493M
| $6.23M | ﹤0.01% |
3,228,360
+377,195
| +13% | +$728K |
|
1353
National Fuel Gas
NFG
$7.97B
| $6.22M | ﹤0.01% |
102,672
+72,802
| +244% | +$4.41M |
|
|
BRSL
1354
Brightstar Lottery PLC
BRSL
$3.12B
| $6.21M | ﹤0.01% |
291,626
+96,019
| +49% | +$2.05M |
|
1355
Immunovant
IMVT
$2.82B
| $6.21M | ﹤0.01% |
217,812
+119,372
| +121% | +$3.4M |
|
1356
PTC Therapeutics
PTCT
$4.85B
| $6.2M | ﹤0.01% |
167,012
+102,138
| +157% | +$3.79M |
|
1357
Sensient Technologies
SXT
$4.52B
| $6.2M | ﹤0.01% |
77,260
+58,386
| +309% | +$4.68M |
|
1358
Affirm
AFRM
$27.1B
| $6.19M | ﹤0.01% |
151,652
+71,118
| +88% | +$2.9M |
|
1359
Blue Bird Corp
BLBD
$1.84B
| $6.17M | ﹤0.01% |
128,658
+116,707
| +977% | +$5.6M |
|
1360
Donaldson
DCI
$9.42B
| $6.17M | ﹤0.01% |
83,738
+13,568
| +19% | +$1,000K |
|
1361
Neogen
NEOG
$1.19B
| $6.17M | ﹤0.01% |
366,753
+207,160
| +130% | +$3.48M |
|
|
PRMW
1362
DELISTED
Primo Water Corporation
PRMW
| $6.16M | ﹤0.01% |
244,054
+166,579
| +215% | +$4.21M |
|
1363
Burford Capital
BUR
$2.82B
| $6.15M | ﹤0.01% |
463,979
-86,320
| -16% | -$1.14M |
|
1364
Evercore
EVR
$13.2B
| $6.14M | ﹤0.01% |
24,251
+798
| +3% | +$202K |
|
1365
Patrick Industries
PATK
$3.67B
| $6.14M | ﹤0.01% |
64,692
+37,266
| +136% | +$3.54M |
|
1366
WSFS Financial
WSFS
$3.13B
| $6.14M | ﹤0.01% |
120,397
+63,284
| +111% | +$3.23M |
|
1367
Archrock
AROC
$4.29B
| $6.13M | ﹤0.01% |
302,610
+167,648
| +124% | +$3.39M |
|
1368
Pacira BioSciences
PCRX
$1.22B
| $6.1M | ﹤0.01% |
405,477
-15,778
| -4% | -$237K |
|
1369
CRISPR Therapeutics
CRSP
$5.12B
| $6.1M | ﹤0.01% |
129,848
+64,228
| +98% | +$3.02M |
|
1370
PVH
PVH
$3.9B
| $6.1M | ﹤0.01% |
60,495
+25,174
| +71% | +$2.54M |
|
1371
Life Time Group Holdings
LTH
$6.29B
| $6.07M | ﹤0.01% |
248,698
+135,116
| +119% | +$3.3M |
|
1372
Hecla Mining
HL
$7.51B
| $6.07M | ﹤0.01% |
909,811
+691,862
| +317% | +$4.62M |
|
1373
Visteon
VC
$3.4B
| $6.07M | ﹤0.01% |
63,716
+23,893
| +60% | +$2.28M |
|
1374
Rush Enterprises Class A
RUSHA
$4.33B
| $6.06M | ﹤0.01% |
114,759
+78,616
| +218% | +$4.15M |
|
1375
Thomson Reuters
TRI
$78B
| $6.06M | ﹤0.01% |
35,516
-19,520
| -35% | -$3.33M |
|